`

BioImagene

Medical Equipment Manufacturing

Specialities :
Digital pathology
Slide scanning systems
Quantitative image analysis
And companion algorithms
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$26.0M
size-icon Size
11 - 50

Frequently Asked Questions About BioImagene

What does Bioimagene do?+

Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Ventana acquired BioImagene in August 2010. Through this acquisition, Ventana is uniquely positioned to deliver an end-to-end solution from automated staining to comprehensive patient reports. Digital Pathology solutions will complement and strengthen Ventanas current offering in image analysis and information management. Ventana digital pathology, powered by BioImagene, provides complete patient-focused solutions that are optimized for clinical labs worldwide. Ventanas digital pathology solutions represent the next step in improving workflow and efficiencies within pathology laboratories. Our solutions are...

What are Bioimagene's specialties? +

Digital pathology,slide scanning systems,quantitative image analysis,and companion algorithms

What is Bioimagene's industry? +

Bioimagene operates in the Medical equipment manufacturing industry.

What is Bioimagene's revenue? +

Bioimagene's revenue is 11m - 100m

What is Bioimagene's company size? +

Bioimagene has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.